Ding! Please sign for your Christmas Eve gift!
Release Date:
2022-12-21 11:38
Quality First, Innovation-Based
Quality First, Innovation Based
With the adjustment of epidemic prevention and control measures, Shanghai has entered a new phase in its fight against the virus. On this invisible battlefield, each of us—striving to live well and working diligently—is a warrior. We are deeply grateful to every colleague who remains steadfast at their post or stays home, tirelessly battling the virus while continuing to do their job. You are all truly outstanding.
In the midst of the pandemic, people have come to appreciate the true significance of health and recognize the profound impact and transformative power that successful drug development can have on humanity. Hycells Biotechnology has wholeheartedly responded to epidemic prevention and control policies, placed great emphasis on the well-being and healthy lifestyles of its employees, and worked diligently to maintain normal business operations and deliver on time as promised to our customers.
In the Hycells Biotechnology R&D Laboratory, a dedicated team of colleagues remains fully committed to ensuring the orderly and stable progress of client service projects, thereby maximizing on-time delivery of Hycells’s services for clients’ subsequent R&D experiments. Quality first, innovation at our core—this is the promise we steadfastly uphold for our clients.
The Human Resources and Administration Department at Hycells has also thoughtfully prepared防疫 (epidemic-prevention) gift packs for everyone, hoping to bring a touch of warmth and our sincerest wishes before the arrival of Christmas Eve this cold winter.
Wishing each of us in advance All are safe and sound. ， Let’s welcome the arrival of the New Year together. Ding! Christmas Eve Gift Please sign for it!
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board